April 30th 2025
Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to innovative therapies for all patients.
Dr Patrick Burnett Explains Mechanism of Action for Roflumilast Cream in Psoriasis
August 25th 2022Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discusses the mechanism of action for roflumilast cream, the only phosphodiesterase-4 inhibitor approved by the FDA for the treatment of plaque psoriasis in patients aged 12 and older.
Watch
Five Additional States, Territories Join Medicaid’s Money Follows the Person Program
August 24th 2022Medicaid’s Money Follows the Person (MFP) demonstration program, which began in 2008, has helped states transition more than 107,000 people to community settings rather than living in institutional facilities.
Read More
COPD Transition Bundle May Lower Risk of Hospital Readmission
August 24th 2022Findings from this multicenter randomized controlled trial showed that the transition bundle was associated with a lower risk of 7-day and 30-day hospital readmission from chronic obstructive pulmonary disease (COPD).
Read More
Clinicians Slow to Adopt PD-1, PD-L1 Inhibitors in NSCLC
August 23rd 2022A significant subset of patients continues to receive chemotherapy monotherapy despite the availability of newer approaches, including programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors.
Read More
Benefits of Dietary Elimination May Not Outweigh Risks in Atopic Dermatitis
August 23rd 2022Findings of a meta-analysis show that use of dietary elimination had a minimal effect on the severity of atopic dermatitis and may increase the risk of developing immunoglobulin E–mediated food allergy.
Read More
Healthy Diet, Exercise Linked With Reduced Mortality Risk in Parkinson Disease
August 22nd 2022Patients with Parkinson disease who adhered to a healthy diet pattern and active lifestyle had a lower rate of all-cause mortality than those reporting poor diet quality and lack of physical activity.
Read More
Better HRQOL, Health Literacy Seen in Systemic Mastocytosis vs Mast Cell Activation Syndrome
August 22nd 2022Systemic mastocytosis and mast cell activation syndrome both negatively impact health-related quality of life (HRQOL), with mast cell activation syndrome patients reporting more significant impacts on everyday life.
Read More
CAR T-Cell Therapy Outcomes Likely Not Influenced by Race/Ethnicity, Obesity
August 21st 2022Researchers studied data from 5 phase 1 studies that took place between 2012 and 2021, comprising 139 infusions among patients with B-cell acute lymphoblastic leukemia who received chimeric antigen receptor (CAR) T-cell treatment.
Read More
Analyzing How Online Learning Prepares Students for Remote Care Settings
August 21st 2022The pandemic has changed how care has delivered, but what professionals new to health care know about strategies used to connect with patients in a virtual setting, or the quality of the instruction they receive, is not known.
Read More
Advocate Speaks on Critical Research Needs in Hidradenitis Suppurativa
August 20th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with hidradenitis suppurativa (HS), spoke on key areas of HS comprehension and management that warrant further investigation in clinical research.
Watch
Adherence to INC Treatment for Nasal Polyposis Remains Low
August 18th 2022Despite intranasal corticosteroid (INCs) being a treatment mainstay for chronic rhinosinusitis with nasal polyps, there are ongoing high rates of nonadherence, which can affect treatment efficacy, according to this study’s authors.
Read More
Drug Survival of Dupilumab Affected by Immunosuppressive Therapy, Older Age in AD
August 18th 2022Investigator Global Assessment score of very severe atopic dermatitis (AD) was associated with dupilumab discontinuation due to adverse effects, although generally adequate 1-, 2-, and 3-year drug survival rates were also observed.
Read More
New Report Highlights Rare Cases of SLE Onset After HPV Vaccination
August 17th 2022A new case report highlights the potential benefits of risk assessment for women with a family history of autoimmune diseases, such as systemic lupus erythematosus (SLE), who are considering the human papillomavirus (HPV) vaccine.
Read More
QCCA Panel Highlights Expansion of Innovation at Independent Community Oncology
August 17th 2022Value management, theranostics, clinical trial access, and a mobile pharmacy are major innovations being integrated into independent community oncology practices, as highlighted at the Quality Cancer Care Alliance Summer 2022 National Leadership Summit.
Read More
Risk of PH Increases With Preterm Birth
August 16th 2022Infants born between the 23rd and 25th weeks of pregnancy, classified as extremely low gestational age newborns, are surviving in increasing numbers, note study authors, and with that is growing clinical interest in their long-term sequelae, including pulmonary hypertension (PH).
Read More
Contributor: Destigmatizing Ketamine for Legitimate Pain Use
August 16th 2022Ketamine has been safely used as an anesthetic in the hospital environment for years, but with the proper training, it can also be administered by a medical professional in a clinical setting to provide pain relief.
Read More